Vít Drochýtek

619 total citations
11 papers, 45 citations indexed

About

Vít Drochýtek is a scholar working on Oncology, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vít Drochýtek has authored 11 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Obstetrics and Gynecology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vít Drochýtek's work include Cancer Risks and Factors (6 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Vít Drochýtek is often cited by papers focused on Cancer Risks and Factors (6 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Vít Drochýtek collaborates with scholars based in Czechia, Belgium and Netherlands. Vít Drochýtek's co-authors include Frédéric Amant, M Halaška, Kristel Van Calsteren, R.G. Shmakov, Robert Fruscio, Lukáš Rob, Julie M. Janssen, Jos H. Beijnen, Alwin D. R. Huitema and Rebecca C. Painter and has published in prestigious journals such as Clinical Pharmacokinetics, Urology and Gynecologic Oncology.

In The Last Decade

Vít Drochýtek

9 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vít Drochýtek Czechia 4 28 14 13 12 10 11 45
Aruyaru Stanley Mwenda Kenya 4 17 0.6× 7 0.5× 13 1.0× 17 1.4× 12 1.2× 10 62
Peter Kaščák Slovakia 5 9 0.3× 14 1.0× 6 0.5× 15 1.3× 7 0.7× 14 52
Ephraim Ohazurike Nigeria 6 23 0.8× 14 1.0× 6 0.5× 44 3.7× 12 1.2× 19 73
Emily Barker United States 6 26 0.9× 9 0.6× 11 0.8× 13 1.1× 37 3.7× 12 85
Norma Deri Argentina 3 17 0.6× 6 0.4× 18 1.4× 3 0.3× 3 0.3× 5 80
Juan Rubiano Colombia 2 26 0.9× 3 0.2× 4 0.3× 8 0.7× 17 1.7× 4 35
Roya Faraji Darkhaneh Iran 6 5 0.2× 27 1.9× 12 0.9× 19 1.6× 5 0.5× 15 75
Katarzyna Kwiatkowska Poland 4 12 0.4× 9 0.6× 28 2.2× 27 2.3× 11 1.1× 8 55
Lily Pham United States 4 10 0.4× 12 0.9× 12 0.9× 8 0.7× 18 1.8× 9 64
Marcin Płonowski Poland 5 22 0.8× 25 1.8× 33 2.5× 7 0.7× 11 59

Countries citing papers authored by Vít Drochýtek

Since Specialization
Citations

This map shows the geographic impact of Vít Drochýtek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vít Drochýtek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vít Drochýtek more than expected).

Fields of papers citing papers by Vít Drochýtek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vít Drochýtek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vít Drochýtek. The network helps show where Vít Drochýtek may publish in the future.

Co-authorship network of co-authors of Vít Drochýtek

This figure shows the co-authorship network connecting the top 25 collaborators of Vít Drochýtek. A scholar is included among the top collaborators of Vít Drochýtek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vít Drochýtek. Vít Drochýtek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sehnal, Borek, M Halaška, Vít Drochýtek, et al.. (2024). Infekce lidským papilomavirem (HPV) a gravidita. PubMed. 73(1). 37–50.
3.
Robová, Helena, et al.. (2023). Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Pregnancy outcomes. Gynecologic Oncology. 174. 76–79. 3 indexed citations
4.
Drochýtek, Vít, et al.. (2022). Analysis of awareness and acceptance of SARS-CoV-2 vaccination among pregnant women. PubMed. 87(2). 100–103. 1 indexed citations
5.
O’Malley, David M., Athina Christopoulou, Myong Cheol Lim, et al.. (2022). O026/#560 Efficacy analysis by disease risk subgroup for the phase 3 athena-mono study (GOG-3020/engot-OV45) evaluating rucaparib maintenance treatment in patients with newly diagnosed ovarian cancer. International Journal of Gynecological Cancer. 32. A16–A16. 3 indexed citations
6.
Janssen, Julie M., Kristel Van Calsteren, Thomas P. C. Dorlo, et al.. (2021). Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP). Clinical Pharmacokinetics. 60(6). 775–784. 18 indexed citations
7.
Halaška, M, Vít Drochýtek, R.G. Shmakov, & Frédéric Amant. (2021). Fertility sparing treatment in cervical cancer management in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology. 75. 101–112. 7 indexed citations
8.
Gerwen, Mathilde van, Martine van Grotel, Marry M. van den Heuvel‐Eibrink, et al.. (2021). Long-term neurodevelopmental outcome after prenatal exposure to maternal hematological malignancies with or without cytotoxic treatment. Child Neuropsychology. 27(6). 822–833. 3 indexed citations
9.
Maggen, Charlotte, Mina Mhallem Gzirí, Paolo Zola, et al.. (2020). Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management. Urology. 151. 118–128. 5 indexed citations
10.
Herman, Jay H., et al.. (2019). Histopathological and clinical features of molar pregnancy.. PubMed. 84(6). 418–424. 4 indexed citations
11.
Rob, Lukáš, et al.. (2019). Individualization of surgical management of cervical cancer stages IA1, IA2.. PubMed. 84(3). 172–176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026